loadpatents
Patent applications and USPTO patent grants for van Meijer; Marja.The latest application filed is for "binding molecules for the treatment of myeloid cell malignancies".
Patent | Date |
---|---|
Binding molecules for the treatment of myeloid cell malignancies Grant 8,632,985 - van den Oudenrijn , et al. January 21, 2 | 2014-01-21 |
Binding Molecules For The Treatment Of Myeloid Cell Malignancies App 20120270802 - van den Oudenrijn; Sonja ;   et al. | 2012-10-25 |
Binding molecules for the treatment of myeloid cell malignancies Grant 8,268,966 - van den Oudenrijn , et al. September 18, 2 | 2012-09-18 |
Human binding molecule against CD1a Grant 7,968,092 - Throsby , et al. June 28, 2 | 2011-06-28 |
Binding molecules for the treatment of myeloid cell malignancies App 20100184671 - van den Oudenrijn; Sonja ;   et al. | 2010-07-22 |
Binding molecules for the treatment of myeloid cell malignancies Grant 7,741,443 - van den Oudenrijn , et al. June 22, 2 | 2010-06-22 |
Human binding molecule against CD1A App 20060257397 - Throsby; Mark ;   et al. | 2006-11-16 |
Binding molecules for the treatment of myeloid cell malignancies App 20060177451 - van den Oudenrijn; Sonja ;   et al. | 2006-08-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.